Our study found that serum glypican-4 levels were significantly elevated in GDM patients during the second and third trimesters of pregnancy, which was consistent with the characteristics of changes in IR during pregnancy, and exhibited the potential of glypican-4 as a serological marker associated with IR. The gene discussed is GPC4; the disease is gestational diabetes.